Dr. Sammar Atassi, MD

Dr. Atassi practices at Montgomery General Hospital in Montgomery, West Virginia, part of Montgomery General Hospital.

Dr. Atassi's NPI, 1396845137, was assigned on September 22, 2006. Dr. Atassi holds West Virginia license 17398.

Dr. Atassi's primary practice is Montgomery General Hospital, at 401 Sixth Avenue, Montgomery, WV 25136 in Fayette County. The practice phone is (304) 442-5151.

Dr. Atassi's primary practice is Montgomery General Hospital in Montgomery, West Virginia, part of Montgomery General Hospital. Dr. Atassi is also affiliated with Charleston Area Medical Center General Hospital. The medical group on file is Montgomery General Hospital. Dmand AI also links Dr. Atassi to 1 more hospital, 1 home health agency, 1 hospice and 1 skilled nursing facility, each named with a free account. Dr. Atassi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atassi practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Atassi's primary specialty in the NPI Registry, under taxonomy code 207RS0012X. The record also lists sleep medicine. Dr. Atassi is licensed in West Virginia.

CMS data shows 184 Medicare services from Dr. Atassi across 1 procedure code in 2024, for 136 Medicare patients. Medicare paid $902 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 136 Medicare patients who saw Dr. Atassi in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Atassi's median patient age at 73, with 56% women.

In 2024, Dr. Atassi wrote 19,827 Medicare Part D claims for 850 patients. 85% of them were for generic drugs. CMS names the drug for 19,009 of them, across 222 drugs with 11 or more claims each, at $1,636,171 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Atassi for performance year 2024, reported through an alternative payment model (APM). Dr. Atassi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 28 general payments to Dr. Atassi from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 78% of the total. Amgen Inc. paid the most, $262.